CureVac NV Earnings Estimate
| CVAC Stock | USD 2.33 0.02 0.87% |
CureVac |
CureVac NV Earnings Estimation Breakdown
The calculation of CureVac NV's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CureVac NV is estimated to be -0.805 with the future projection ranging from a low of -1.0725 to a high of -0.6025. Please be aware that this consensus of annual earnings estimates for CureVac NV is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.07 Lowest | Expected EPS | -0.6 Highest |
CureVac NV Earnings Projection Consensus
Suppose the current estimates of CureVac NV's value are higher than the current market price of the CureVac NV stock. In this case, investors may conclude that CureVac NV is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CureVac NV's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2021 | Current EPS (TTM) | |
| 0 | 81.98% | -0.825 | -0.805 | -1.57 |
CureVac NV Earnings per Share Projection vs Actual
Actual Earning per Share of CureVac NV refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering CureVac NV predict the company's earnings will be in the future. The higher the earnings per share of CureVac NV, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.CureVac NV Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as CureVac NV, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of CureVac NV should always be considered in relation to other companies to make a more educated investment decision.CureVac Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact CureVac NV's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-14 | 2023-09-30 | -0.23 | -0.22 | 0.01 | 4 | ||
2023-08-17 | 2023-06-30 | -0.24 | -0.3 | -0.06 | 25 | ||
2023-05-30 | 2023-03-31 | -0.34 | -0.27 | 0.07 | 20 | ||
2022-12-31 | 2022-12-31 | -0.34 | -0.66 | -0.32 | 94 | ||
2022-11-16 | 2022-09-30 | -0.27 | -0.25 | 0.02 | 7 | ||
2022-08-18 | 2022-06-30 | -0.26 | -0.31 | -0.05 | 19 | ||
2022-05-25 | 2022-03-31 | -0.5 | -0.08 | 0.42 | 84 | ||
2021-11-18 | 2021-09-30 | -0.73 | -0.77 | -0.04 | 5 | ||
2021-08-16 | 2021-06-30 | -0.85 | -0.825 | 0.025 | 2 | ||
2021-04-15 | 2021-03-31 | -0.51 | -0.33 | 0.18 | 35 | ||
2020-12-31 | 2020-12-31 | -0.61 | -0.38 | 0.23 | 37 | ||
2020-11-30 | 2020-09-30 | -0.35 | -0.24 | 0.11 | 31 | ||
2020-08-14 | 2020-06-30 | -54.37 | -0.29 | 54.08 | 99 |
About CureVac NV Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CureVac NV earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CureVac NV estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CureVac NV fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -1.2 B | -1.2 B | |
| Earnings Yield | (0.27) | (0.25) | |
| Price Earnings Ratio | (3.86) | (4.06) | |
| Price Earnings To Growth Ratio | 0.1 | 0.10 |
Pair Trading with CureVac NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CureVac NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will appreciate offsetting losses from the drop in the long position's value.Moving against CureVac Stock
| 0.76 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.71 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.68 | ELYM | Eliem Therapeutics Upward Rally | PairCorr |
| 0.61 | HCWB | HCW Biologics | PairCorr |
| 0.56 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to CureVac NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CureVac NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CureVac NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CureVac NV to buy it.
The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CureVac NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CureVac NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CureVac NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.Note that the CureVac NV information on this page should be used as a complementary analysis to other CureVac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is CureVac NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share 0.244 | Quarterly Revenue Growth 0.931 | Return On Assets (0.21) | Return On Equity (0.50) |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.